The Filing Desk

Castle Biosciences vs Viemed Healthcare

Castle Biosciences CSTL · Viemed Healthcare VMD · Health Care Services

Castle Biosciences reported revenue of $344 million in fiscal 2025, 1.3 times Viemed Healthcare's $270 million in fiscal 2025. Castle Biosciences' revenue grew 3.7% in its latest year, and Viemed Healthcare's grew 20.5%. Castle Biosciences had an operating margin of -12.4%, against 8.5% at Viemed Healthcare. Free cash flow was $28 million at Castle Biosciences and $12 million at Viemed Healthcare.

Side by side

Castle BiosciencesViemed Healthcare
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$344M$270M
Revenue growth3.7%20.5%
Revenue growth a year, last 5 years40.6%15.5%
Gross margin79.4%57.5%
Operating margin−12.4%8.5%
Net margin−7.0%5.5%
Free cash flow$28M$12M
Free cash flow margin8.2%4.4%
Return on capital−19.1%12.4%
Net debt to EBITDA—−0.0x
Dividends and buybacks$0M$13M
Change in diluted share count−0.9%0.1%
Last close$33.41$8.61
P/E at the last close—22.7×
Insider trades, last 12 monthssold $16.6 millionsold $1.6 million
Piotroski F-score4 of 95 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Castle BiosciencesViemed Healthcare
Operating margin
Percent of revenue
Castle BiosciencesViemed Healthcare
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Castle BiosciencesViemed Healthcare

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Castle Biosciences and Viemed Healthcare pages.